Breaking News
Sort by:
Top Post
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
ObvioHealth Announces Ground-Breaking Digital Therapeutics API to Capture More Accurate Efficacy and Adherence Data in Clinical Trials
ObvioHealth, a pioneering virtual research organization, announces the launch of a proprietary application programming interface […]
Vysioneer Announces Data Sharing Agreement with Pfizer to Augment Oncology Clinical Trials with Artificial Intelligence
Vysioneer, a pioneer in AI for Oncology, today announced a data-sharing agreement with Pfizer, a […]
OxSonics Announces First-in-human Clinical Data Shows SonoTran(R) is Safe and Well-tolerated
OxSonics Therapeutics, a clinical-stage medtech company focused on transforming cancer treatment through SonoTran, its proprietary […]
Huma to Provide Best-in-class Digital Clinical Trials Solutions Through Landmark Acquisition of Alcedis
Huma Therapeutics, a leading global digital health company, today announced that it has acquired Alcedis […]
Sustained Therapeutics Advancing Clinical Trial for Novel Drug Delivery Platform
A Vancouver-based therapeutics company, Sustained Therapeutics, has received regulatory approval to begin the second Phase […]
OnQuality Pharmaceuticals Expands Part 2 of the NOVA-II Phase 2 Clinical Trial to China and India
OnQuality Pharmaceuticals, a targeted oncology supportive therapy company developing innovative medications to address the quality […]
- Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Read more
- Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) Read more
- BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Read more
- Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution Read more
- GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Read more